Product Description

The Humana CRUSH Report is a Global 500 deep dive company profile report that contains sales intelligence not available in any other data source on the planet.

The Humana CRUSH Report contains IT architectures, org charts, decision maker contact info, corporate strategies, relevant news, and insights to budgets, IT projects, and major initiatives.

The Humana CRUSH Report was developed to help high tech sales reps eliminate costly research time, uncover sales opportunities, and drive new sales revenues faster.

CRUSH customers use CRUSH Reports and CRUSH Alerts to:
  • jump-start new sales reps
  • develop strategic account plans
  • write VITO letters
  • identify competitors & build target account lists
  • build competitive displacement programs
  • write winning RFP responses
  • eliminate sales research time
  • reduce sales cycles
Download the CRUSH Report Use Case PDF to learn more...

Organizational Chart - Sample

Financial Information

Company: Humana

Global 500 Rank: 289

Revenues: 39130

Fiscal End Year: December

Ticker: HUM

Number of Employees: 43400

Industry: Health Care: Insurance and Managed Care

Address: 500 West Main St.

City: Louisville

State: KY

Country: USA

Phone: 502-580-1000

Fax: 502-580-3677

Company Website: http://www.humana.com

CRUSH Reports Related to Humana
@Humana
Humana News Feed

Humana Inc. to Present at the UBS Global Healthcare Conference
Friday May 17th 2013 11:45:00 AM

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that James H. Bloem, Senior Vice President, Chief Financial Officer and Treasurer will make a presentation to investors at the UBS Global Healthcare Conference on Tuesday, May 21, 2013, at 9:30 a.m. eastern time. A live audio webcast of the presentation along with the accompanying slides will be available via Humana’s Investor Relations page at www.humana.com. The company suggests webcast participants sign on approximately

Humana Appoints Roy A. Beveridge, M.D., as Chief Medical Officer
Thursday May 9th 2013 08:45:00 AM

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced today that Roy A. Beveridge, M.D. has been appointed Senior Vice President and Chief Medical Officer, effective June 17. Dr. Beveridge will serve on the company’s Executive Team and report to President and Chief Executive Officer Bruce Broussard. He’ll be responsible for developing Humana’s clinical strategy as well as policies for clinical employees (associates) acro

Humana Named in the Top Ten for Military Times’ 2013 “Best Employers for Vets”
Wednesday May 8th 2013 01:46:00 PM

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announces its ranking of eighth in the Military Times EDGE magazine’s “Best Employers for Vets 2013.” Military Times is a weekly publication for active duty and retired personnel of the U.S. Army, Navy, Air Force, and Marine Corps subscribers. Military Times invited major corporations and government contractors across the country to submit a detailed questionnaire about hiring policies/recruiting, company policies relating to veterans, Gu

Humana Adding Approximately 500 Jobs Nationwide
Wednesday May 8th 2013 10:00:00 AM

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Adding Approximately 500 Jobs Nationwide - Company to add full-time Direct Marketing Services Telesales Positions

HumanaVitality and Competitor Group announce Rock ‘n’ Roll Sponsorship
Tuesday May 7th 2013 01:24:00 PM

CHICAGO--(BUSINESS WIRE)--HumanaVitality named as presenting sponsor of Rock ‘n’ Roll Chicago Half Marathon.

Humana Inc. Releases First Quarter 2013 Financial Results
Wednesday May 1st 2013 06:00:00 AM

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today issued a detailed press release reporting diluted earnings per common share (EPS) for the quarter ended March 31, 2013 (1Q13) of $2.95, compared to $1.49 per share for the quarter ended March 31, 2012. Results for 1Q13 exceeded management’s previous expectations of $1.75 to $1.85 primarily due to outperformance across the company’s portfolio of businesses as well as the beneficial effect of certain discrete items and a lower-than-pr